THERADIAG Signs a Contract to Supply ORGENTEC With Quality Control Reagents Called Alegria Check THERADIAG (Paris:ALTER) (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today announces that it has signed an partnership contract with ORGENTEC, a German company that is a leader on the global autoimmunity market, to provide it with quality control reagents called Alegria Check. Medical analysis laboratories are having to comply with increasingly stringent regulatory requirements in terms of quality control. Theradiag has developed expertise in quality control products over many years. To meet these growing demands, Theradiag will manufacture and supply ORGENTEC, from 2021 and for at least the next three years, with multiparametric quality controls enabling the Alegria system's performances to be monitored. Alegria is a fully automatic analytical instrument developed by ORGENTEC for the diagnosis of autoimmune disorders and infectious diseases. There are 7 Alegria Check control kits that verify the results of 15 autoimmune parameters available on the instrument.